Raynaud’s May Be Linked to Formation of Finger Pad Tophi, Case Study Suggests
News
Raynaud’s phenomenon may be linked to the formation of tophi, or deposits of uric acid crystals, in the finger pads, suggests ... Read more
Estrogen Likely Contributes to Cold-induced Raynaud’s in Women
News
Estrogen may contribute to the development of Raynaud’s phenomenon in women, according to a study examining the relationship between palm blood ... Read more
FDA Grants Cytori Therapeutics Small Business Status in the US
News
The U.S. Food and Drug Administration (FDA) has granted Cytori Therapeutics Small Business status designation for fiscal year 2017, meaning that the company ... Read more
Raynaud’s Case Report Highlights Need for Cautious Glucose Monitoring to Avoid Overtreatment
News
Recognizing the signs and early identification of artifactual hypoglycemia in patients with Raynaud’s phenomenon and/or systemic sclerosis is critical to prevent ... Read more
Case Report Documents Severe Secondary Raynaud’s in Black-African Woman
News
A case report of severe Raynaud’s phenomenon in a black-African woman illustrates the difficulties clinicians still face for diagnosis and management. ... Read more
In Rare Case, Raynauld’s Symptoms Stopped by Treating Underlying Blood Disorder
News
Raynaud’s symptoms ceased in a woman after treatment with hydroxycarbamide returned her platelet count to normal, according to a case study published in ... Read more
Cytori to Include Raynaud’s Phenomenon in Its Scleroderma Cell Therapy Program
News
Cytori Therapeutics will expand the development of its ECCS-50 scleroderma treatment to include secondary Raynaud’s phenomenon (RP), under the brand Habeo ... Read more
Clinical Trial Finds No Evidence that Acupressure is Effective for Treating Raynaud’s
News
A randomized, controlled clinical trial was performed to evaluate the effects of acupressure on Raynaud’s phenomenon (RP), however, no significant impact ... Read more
Raynaud’s Phenomenon Most Common Symptom Signaling Mixed Connective Tissue Disease
News
Raynaud’s phenomenon may signal the development of mixed connective tissue disease, as a study showed that it was the most common ... Read more
Revlimid May Effectively Treat Raynaud’s Phenomenon in Pediatric SLE, Study Shows
News
Revlimid (lenalidomide) was found to effectively treat skin manifestations in adolescents with systemic lupus erythematosus, including Raynaud’s phenomenon. The study, “Lenalidomide ... Read more
Study Finds Reduced Blood Flow in Heart Tissue of Raynaud’s Patients
News
Patients with both primary and secondary Raynaud’s phenomenon have an abnormally low blood penetration in the heart tissue, which likely explains ... Read more
Extension Study Gets Underway for Resunab as Treatment for Dermatomyositis Patients
News
Corbus Pharmaceuticals is starting a one-year, open-label extension study for the ongoing Phase 2 clinical trial evaluating the effect of Resunab in ... Read more